These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32977849)

  • 1. Similarities and differences in key diagnosis, treatment, and management approaches for PAH deficiency in the United States and Europe.
    Lowe TB; DeLuca J; Arnold GL
    Orphanet J Rare Dis; 2020 Sep; 15(1):266. PubMed ID: 32977849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional management of phenylalanine hydroxylase (PAH) deficiency in pediatric patients in Canada: a survey of dietitians' current practices.
    Yuskiv N; Potter BK; Stockler S; Ueda K; Giezen A; Cheng B; Langley E; Ratko S; Austin V; Chapman M; Chakraborty P; Collet JP; Pender A;
    Orphanet J Rare Dis; 2019 Jan; 14(1):7. PubMed ID: 30621767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenylalanine hydroxylase deficiency treatment and management: A systematic evidence review of the American College of Medical Genetics and Genomics (ACMG).
    Adams AD; Fiesco-Roa MÓ; Wong L; Jenkins GP; Malinowski J; Demarest OM; Rothberg PG; Hobert JA;
    Genet Med; 2023 Sep; 25(9):100358. PubMed ID: 37470789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complete European guidelines on phenylketonuria: diagnosis and treatment.
    van Wegberg AMJ; MacDonald A; Ahring K; Bélanger-Quintana A; Blau N; Bosch AM; Burlina A; Campistol J; Feillet F; Giżewska M; Huijbregts SC; Kearney S; Leuzzi V; Maillot F; Muntau AC; van Rijn M; Trefz F; Walter JH; van Spronsen FJ
    Orphanet J Rare Dis; 2017 Oct; 12(1):162. PubMed ID: 29025426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Women With Phenylalanine Hydroxylase Deficiency (Phenylketonuria): ACOG Committee Opinion, Number 802.
    Obstet Gynecol; 2020 Apr; 135(4):e167-e170. PubMed ID: 32217978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Women With Phenylalanine Hydroxylase Deficiency (Phenylketonuria): ACOG Committee Opinion Summary, Number 802.
    Obstet Gynecol; 2020 Apr; 135(4):987-988. PubMed ID: 32217972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylalanine hydroxylase deficiency: diagnosis and management guideline.
    Vockley J; Andersson HC; Antshel KM; Braverman NE; Burton BK; Frazier DM; Mitchell J; Smith WE; Thompson BH; Berry SA;
    Genet Med; 2014 Feb; 16(2):188-200. PubMed ID: 24385074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of phenylketonuria in adult patients in Italy: a survey of six specialist metabolic centers.
    Burlina A; Leuzzi V; Spada M; Carbone MT; Paci S; Tummolo A
    Curr Med Res Opin; 2021 Mar; 37(3):411-421. PubMed ID: 33222540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to clinic recommendations among patients with phenylketonuria in the United States.
    Jurecki ER; Cederbaum S; Kopesky J; Perry K; Rohr F; Sanchez-Valle A; Viau KS; Sheinin MY; Cohen-Pfeffer JL
    Mol Genet Metab; 2017 Mar; 120(3):190-197. PubMed ID: 28162992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria.
    Muntau AC; Adams DJ; Bélanger-Quintana A; Bushueva TV; Cerone R; Chien YH; Chiesa A; Coşkun T; de Las Heras J; Feillet F; Katz R; Lagler F; Piazzon F; Rohr F; van Spronsen FJ; Vargas P; Wilcox G; Bhattacharya K
    Mol Genet Metab; 2019 May; 127(1):1-11. PubMed ID: 31103398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM).
    Thomas J; Levy H; Amato S; Vockley J; Zori R; Dimmock D; Harding CO; Bilder DA; Weng HH; Olbertz J; Merilainen M; Jiang J; Larimore K; Gupta S; Gu Z; Northrup H;
    Mol Genet Metab; 2018 May; 124(1):27-38. PubMed ID: 29653686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutrition management of PKU with pegvaliase therapy: update of the web-based PKU nutrition management guideline recommendations.
    Cunningham A; Rohr F; Splett P; Mofidi S; Bausell H; Stembridge A; Kenneson A; Singh RH
    Orphanet J Rare Dis; 2023 Jun; 18(1):155. PubMed ID: 37349772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylketonuria Scientific Review Conference: state of the science and future research needs.
    Camp KM; Parisi MA; Acosta PB; Berry GT; Bilder DA; Blau N; Bodamer OA; Brosco JP; Brown CS; Burlina AB; Burton BK; Chang CS; Coates PM; Cunningham AC; Dobrowolski SF; Ferguson JH; Franklin TD; Frazier DM; Grange DK; Greene CL; Groft SC; Harding CO; Howell RR; Huntington KL; Hyatt-Knorr HD; Jevaji IP; Levy HL; Lichter-Konecki U; Lindegren ML; Lloyd-Puryear MA; Matalon K; MacDonald A; McPheeters ML; Mitchell JJ; Mofidi S; Moseley KD; Mueller CM; Mulberg AE; Nerurkar LS; Ogata BN; Pariser AR; Prasad S; Pridjian G; Rasmussen SA; Reddy UM; Rohr FJ; Singh RH; Sirrs SM; Stremer SE; Tagle DA; Thompson SM; Urv TK; Utz JR; van Spronsen F; Vockley J; Waisbren SE; Weglicki LS; White DA; Whitley CB; Wilfond BS; Yannicelli S; Young JM
    Mol Genet Metab; 2014 Jun; 112(2):87-122. PubMed ID: 24667081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results.
    Giżewska M; MacDonald A; Bélanger-Quintana A; Burlina A; Cleary M; Coşkun T; Feillet F; Muntau AC; Trefz FK; van Spronsen FJ; Blau N
    Eur J Pediatr; 2016 Feb; 175(2):261-72. PubMed ID: 26350228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sapropterin dihydrochloride: a new drug and a new concept in the management of phenylketonuria.
    Trefz FK; Belanger-Quintana A
    Drugs Today (Barc); 2010 Aug; 46(8):589-600. PubMed ID: 20830319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of children and adults with phenylketonuria in the NBS-PKU Connect registry.
    Kenneson A; Singh RH
    Mol Genet Metab; 2021 Nov; 134(3):243-249. PubMed ID: 34654619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to tetrahydrobiopterin therapy in patients with phenylketonuria.
    Rohr F; Wessel A; Brown M; Charette K; Levy HL
    Mol Genet Metab; 2015 Jan; 114(1):25-8. PubMed ID: 25467057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
    Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
    Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive, neuropsychiatric, and neurological outcomes associated with phenylalanine hydroxylase deficiency: Assessment considerations for nurse practitioners.
    Lowe TB; DeLuca J; Arnold G
    J Spec Pediatr Nurs; 2021 Jan; 26(1):e12312. PubMed ID: 32956570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.